RecruitingNot ApplicableNCT06083298

Multifidus Cervicis and Inter-Semispinal Plane Blocks in Analgesia After Cervical Spine Surgery

Comparison Between Multifidus Cervicis and Inter-semispinal Plane Blocks in Analgesia After Cervical Spine Surgery: A Randomized Controlled Trial


Sponsor

Zagazig University

Enrollment

105 participants

Start Date

Oct 20, 2023

Study Type

INTERVENTIONAL

Summary

Major spine surgery with multilevel instrumentation is followed by a large amount of opioid consumption, significant pain, and difficult mobilization Pain is one of the main factors limiting ambulation, increasing the risk of thromboembolism by immobility, and causing metabolic changes that affect other systems. Therefore, individualized pain management with the use of appropriate analgesic techniques is of paramount importance. Moreover, early intervention in rehabilitation aiming at a better postoperative recovery may reduce the length of hospital stay and return to daily activity. Effective pain management is one of the crucial components in enhanced recovery after surgery (ERAS). Numerous regional anesthetic techniques have been used to provide analgesia following cervical spine surgery, including patient-controlled epidural analgesia, cervical paravertebral block, cervical plexus block, cervical erector spinae plane blocks, and local infiltration analgesia, however, each of these techniques has specific limitations that prevent them from being the analgesic technique of choice for such surgeries. Up to the author's knowledge, there is no study done to compare multifidus cervicis plane block versus inter-semispinal plane block in a randomized controlled clinical trial as preemptive analgesia in patients undergoing cervical spine surgery.


Eligibility

Min Age: 21 YearsMax Age: 60 Years

Inclusion Criteria5

  • Patient acceptance.
  • Age 21-60 years old.
  • BMI ≤ 30 kg/m2
  • ASA I - II.
  • Elective posterior cervical spine surgery under general anesthesia.

Exclusion Criteria5

  • History of allergy to the LA agents used in this study
  • Skin lesion at the needle insertion site,
  • Those with bleeding disorders, sepsis, liver disease, and psychiatric disorders
  • History of chronic pain and taking analgesics
  • History of cognitive dysfunction or mental illness

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREcontrol group

patients will be operated under general anesthesia

PROCEDUREMCP group

patients will receive ultrasound-guided MCP block with 15 ml of bupivacaine 0.25% on each side followed by general anesthesia.

PROCEDUREISP group

patients will receive ultrasound-guided ISP block with 15 ml of bupivacaine 0.25% on each side followed by general anesthesia.


Locations(1)

Faculty of medicine, zagazig university

Zagazig, Alsharqia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06083298